Safety and immunogenicity of inactive vaccines as booster doses for COVID-19 in Türkiye: A randomized trial

Protective neutralizing antibody titers reduce in time after COVID-19 vaccinations, as in individuals who have had COVID-19. This study aimed to evaluate the safety and immunogenicity of CoronaVac and TURKOVAC vaccines used as a booster dose after CoronaVac primary vaccination. This double-blind, ra...

Descripción completa

Detalles Bibliográficos
Autores principales: Omma, Ahmet, Batirel, Ayse, Aydin, Mehtap, Yilmaz Karadag, Fatma, Erden, Abdulsamet, Kucuksahin, Orhan, Armagan, Berkan, Güven, Serdar Can, Karakas, Ozlem, Gokdemir, Selim, Altunal, Lutfiye Nilsun, Buber, Aslihan Ayse, Gemcioglu, Emin, Zengin, Oguzhan, Inan, Osman, Sahiner, Enes Seyda, Korukluoglu, Gulay, Sezer, Zafer, Ozdarendeli, Aykut, Kara, Ates, Ates, Ihsan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2022
Materias:
Coronavirus – Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9746394/
https://www.ncbi.nlm.nih.gov/pubmed/36315843
http://dx.doi.org/10.1080/21645515.2022.2122503

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9746394/
https://www.ncbi.nlm.nih.gov/pubmed/36315843
http://dx.doi.org/10.1080/21645515.2022.2122503

Ejemplares similares